Brain and Cognitive Health BPC-157 is evidenced to have neuroprotective properties, attenuating damage due to strokes and central nervous system injuries while balancing neurotransmitters to combat symptoms of depression, Parkinsons disease, and schizophrenia [2, 11, 34]

Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
Canary Medical Inc
These findings suggest that a decrease in anti-oxidative agents is a risk factor for glaucoma onset and progression
Lets dive into the science, studies, treatments & what to layer it with to make it even more effective
Semax Semax, which was developed decades ago in Russia, has been investigated for cognitive disorders and stroke recovery